Cargando…
Targeting and Specific Activation of Antigen‐Presenting Cells by Endogenous Antigen‐Loaded Nanoparticles Elicits Tumor‐Specific Immunity
Immunotherapy has shown tremendous promise for improving cancer treatment. Unfortunately, antigen‐presenting cells (APCs) in cancer patients cannot effectively recognize and process tumor antigens to activate host immune responses. In this study, an approach is developed to improve cancer immunother...
Autores principales: | Chang, Hao‐Cai, Zou, Zheng‐Zhi, Wang, Qiu‐Hong, Li, Jie, Jin, Huan, Yin, Qian‐Xia, Xing, Da |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947714/ https://www.ncbi.nlm.nih.gov/pubmed/31921548 http://dx.doi.org/10.1002/advs.201900069 |
Ejemplares similares
-
Nanoparticle dose and antigen loading attenuate antigen‐specific T‐cell responses
por: Casey, Liam M., et al.
Publicado: (2022) -
Nanoparticle-enabled innate immune stimulation activates endogenous tumor-infiltrating T cells with broad antigen specificities
por: Yin, Qian, et al.
Publicado: (2021) -
Mechanism of Antigen
Presentation and Specificity
of Antibody Cross-Reactivity Elicited by an Oligosaccharide-Conjugate
Cancer Vaccine
por: Wang, Szu-Wen, et al.
Publicado: (2023) -
Vaccination with mycobacterial lipid loaded nanoparticle leads to lipid antigen persistence and memory differentiation of antigen-specific T cells
por: Morgun, Eva, et al.
Publicado: (2023) -
Vaccination with mycobacterial lipid loaded nanoparticle leads to lipid antigen persistence and memory differentiation of antigen-specific T cells
por: Morgun, Eva, et al.
Publicado: (2023)